Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

MULTİDİMENSİONAL ASSESSMENT OF MUSCLE FATİGUE İN SOCCER PLAYERS (MAMF)

18 de junio de 2026 actualizado por: Tugce Namazci, Giresun University

MULTIDIMENSIONAL ASSESSMENT OF MUSCLE FATIGUE USING ACCELEROMETER, ELECTROMYOGRAPHY AND MUSCLE THICKNESS DATA

Muscle fatigue is a multifactorial physiological phenomenon characterized by a reduction in the ability of a muscle to generate force during sustained or repetitive contractions. This cross-sectional observational study aimed to investigate the relationships among muscle thickness, surface electromyography (sEMG) median frequency, accelerometer-derived mechanical vibration parameters, and isometric force characteristics in healthy male soccer players. Thirty participants aged 18-30 years underwent ultrasonographic muscle thickness assessment, synchronized sEMG and accelerometer recordings, and isometric strength testing at different knee flexion angles (90°, 60°, and 30°). The study evaluated the interaction between morphological, electrical, and mechanical indicators of muscle fatigue to support the development of multidimensional fatigue monitoring approaches.

Descripción general del estudio

Estado

Terminado

Condiciones

Descripción detallada

Muscle fatigue is commonly assessed using surface electromyography (sEMG), particularly through frequency-domain parameters such as median frequency. However, fatigue-related changes are not limited to electrical activity and may also involve alterations in muscle mechanical behavior and morphological characteristics. Accelerometer-derived signals provide information regarding muscle vibrations and mechanical oscillations, while ultrasonographic measurements of muscle thickness provide information about muscle morphology and force-generating capacity.

The purpose of this study was to examine the relationships among muscle thickness, sEMG median frequency, accelerometer-derived mechanical vibration parameters, and isometric force variables during maximal voluntary isometric contractions performed at different knee flexion angles. Healthy male soccer players participated in a laboratory-based assessment protocol including ultrasonography, synchronized sEMG recordings, triaxial accelerometry, and isokinetic dynamometry.

Muscle thickness of the vastus lateralis obliquus (VLO), vastus medialis obliquus (VMO), and rectus femoris obliquus (RFO) muscles was measured using ultrasonography. Participants subsequently performed maximal voluntary isometric contractions at 90°, 60°, and 30° knee flexion angles. Surface electromyography, accelerometer signals, and force-related variables were recorded simultaneously. Median frequency values, acceleration-based root mean square (RMS) parameters, peak torque, mean torque, and time-to-peak torque variables were analyzed.

The study aimed to provide a multidimensional framework for muscle fatigue assessment by integrating morphological, electrical, and mechanical indicators and to explore their associations in healthy athletic populations.

Tipo de estudio

De observación

Inscripción (Actual)

30

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Merkez
      • Ordu, Merkez, Turquía (Türkiye), 52100
        • Ordu University Faculty of Sports Sciences

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Sí

Método de muestreo

Muestra no probabilística

Población de estudio

Healthy male soccer players aged 18 to 30 years who were actively participating in regular football training and competition. Participants were recruited from football teams and underwent assessments of muscle thickness, surface electromyography (sEMG), accelerometer-derived mechanical vibration parameters, and isometric strength during laboratory-based testing sessions. Only individuals meeting all eligibility criteria and providing informed consent were included in the study.

Descripción

Inclusion Criteria:

  • Healthy male soccer players aged 18-30 years
  • No lower extremity injury within the previous six months
  • No condition limiting lower extremity exercise performance
  • No caffeine or stimulant consumption on the testing day
  • Non-smoker
  • Provided written informed consent

Exclusion Criteria:

  • Female athletes
  • Serious injury to the dominant leg within the previous year
  • Intense exercise within the previous 24 hours
  • Use of pain relievers or muscle relaxants on the testing day
  • Inability to complete testing procedures

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Healthy Male Soccer Players
Healthy male soccer players aged 18-30 years who participated in a cross-sectional observational study. Participants underwent ultrasonographic muscle thickness assessment, surface electromyography (sEMG), accelerometer-based mechanical vibration measurements, and isometric strength testing during maximal voluntary isometric contractions performed at different knee flexion angles (30°, 60°, and 90°).
Participants underwent non-invasive neuromuscular assessment procedures using surface electromyography (sEMG), triaxial accelerometers, ultrasonography, and an isokinetic dynamometer. Measurements were performed during maximal voluntary isometric contractions at 30°, 60°, and 90° knee flexion angles. The devices were used exclusively for data collection and assessment purposes. No therapeutic, pharmacological, behavioral, or rehabilitative intervention was administered.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Surface Electromyography (sEMG) Median Frequency
Periodo de tiempo: Day 1
Median frequency (Hz) obtained from the vastus lateralis obliquus (VLO), vastus medialis obliquus (VMO), and rectus femoris obliquus (RFO) muscles during maximal voluntary isometric contractions performed at 30°, 60°, and 90° knee flexion angles.
Day 1

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Muscle Thickness
Periodo de tiempo: Day 1
Ultrasonographic muscle thickness measurements of the VLO, VMO, and RFO muscles (mm).
Day 1
Accelerometer-Derived Mechanical Vibration Parameters
Periodo de tiempo: Day 1
Root mean square (RMS) acceleration values obtained from thigh and shank triaxial accelerometers during isometric contractions.
Day 1
Isometric Strength Parameters
Periodo de tiempo: Day 1
Peak torque, mean torque, and time-to-peak torque measured using an isokinetic dynamometer during maximal voluntary isometric contractions.
Day 1

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Tuğçe Namazcı, PhD, Giresun Üniversitesi

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de noviembre de 2024

Finalización primaria (Actual)

20 de febrero de 2025

Finalización del estudio (Actual)

15 de marzo de 2025

Fechas de registro del estudio

Enviado por primera vez

12 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

18 de junio de 2026

Publicado por primera vez (Actual)

24 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

24 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

18 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • TN-2024-127

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be publicly shared. The study was conducted as part of a doctoral thesis, and no formal data-sharing plan has been established. Aggregate study results are reported in publications, while access to underlying data may be considered by the corresponding author on a reasonable request basis and in accordance with applicable ethical and institutional requirements.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir